Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2021
- Source ID
- 10.1080/2162402x.2020.1838140
Entities
People
- Alan L. Epstein
- Babak Moghimi
- G. Esteban Fernandez
- Hiroyuki Shimada
- Long T. Hung
- Michael A. Sheard
- Michael D. Hadjidaniel
- Muller Fabbri
- Randall Y. Chan
- Rebekah Kennedy
- Sakunthala Muthugounder
- Shahab Asgharzadeh
- Shilpa Shahani
- Soheila Shirinbak
Organizations
- Center for Cancer Research
- Children's Hospital Los Angeles
- National Cancer Institute
- United States Department of Defense
- University of Hawaiʻi System
- University of Southern California